An amyloid inhibitor octapeptide forms amyloid type fibrous aggregates and affects microtubule motility.
An amyloid inhibitor octapeptide simultaneously forms amyloid type fibrous aggregates on its own and interacts with the microtubule lattice three times stronger than a Xenopus Microtubule Associated Protein (XMAP215).